WallStreetZenWallStreetZen

NASDAQ: LUNG
Pulmonx Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for LUNG

Based on 6 analysts offering 12 month price targets for Pulmonx Corp.
Min Forecast
$8.00-37.25%
Avg Forecast
$14.33+12.42%
Max Forecast
$20.00+56.86%

Should I buy or sell LUNG stock?

Based on 6 analysts offering ratings for Pulmonx Corp.
Buy
Strong Buy
4 analysts 66.67%
Buy
0 analysts 0%
Hold
1 analysts 16.67%
Sell
1 analysts 16.67%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their LUNG stock forecasts and price targets.

LUNG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Citigroup
Top 3%
98
Strong BuyMaintains$14.00+9.80%2023-05-03
Piper Sandler
Bottom 16%
16
Strong BuyMaintains$15.00+17.65%2023-05-03Find out why
Morgan Stanley
Bottom 10%
10
HoldMaintains$14.00+9.80%2023-05-03
Wells Fargo
Top 9%
92
Strong BuyUpgrades$15.00+17.65%2023-02-27Find out why
Canaccord Genuity
Bottom 17%
17
Strong BuyMaintains$20.00+56.86%2023-02-23
Bank of America
Top 31%
70
SellDowngrades$8.00-37.25%2023-01-03

1 of 1

Forecast return on equity

Is LUNG forecast to generate an efficient return?
Company
N/A
Industry
0.02%
Market
71.69%

Forecast return on assets

Is LUNG forecast to generate an efficient return on assets?
Company
N/A
Industry
0.02%

LUNG revenue growth forecast

How is LUNG forecast to perform vs Medical Devices companies and vs the US market?
Company
29.93%
Industry
6.59%
Market
8.46%
LUNG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LUNG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LUNG vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
LUNG$12.75$14.33+12.42%Buy
BFLY$2.21$2.25+1.81%Hold
OBIO$15.41$17.50+13.56%Strong Buy
TCMD$24.23$27.33+12.81%Strong Buy
AXGN$8.97$17.50+95.09%Strong Buy
View Top Medical Device Stocks

Pulmonx Stock Forecast FAQ

Is Pulmonx Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: LUNG) stock is to Buy LUNG stock.

Out of 6 analysts, 4 (66.67%) are recommending LUNG as a Strong Buy, 0 (0%) are recommending LUNG as a Buy, 1 (16.67%) are recommending LUNG as a Hold, 1 (16.67%) are recommending LUNG as a Sell, and 0 (0%) are recommending LUNG as a Strong Sell.

If you're new to stock investing, here's how to buy Pulmonx stock.

What is LUNG's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: LUNG) forecast ROE is N/A, which is considered weak.

What is LUNG's Price Target?

According to 6 Wall Street analysts that have issued a 1 year LUNG price target, the average LUNG price target is $14.33, with the highest LUNG stock price forecast at $20.00 and the lowest LUNG stock price forecast at $8.00.

On average, Wall Street analysts predict that Pulmonx's share price could reach $14.33 by May 3, 2024. The average Pulmonx stock price prediction forecasts a potential upside of 12.42% from the current LUNG share price of $12.75.

What is LUNG's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: LUNG) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 0.02%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.